NEWSNews

2020.11.20[Club Announcement]

12/12(Sat) Cooperation on Introducing Solutions for Preventing the Spread of COVID-19 in the Hiroshima Match

We would like to inform you that FC Tokyo will be cooperating in the trial introduction of the new coronavirus infection control solution "MyPass" in order to provide a safer and more secure viewing experience for many people in official matches and other professional sports.
This is part of the government's "technology development measures to resume large-scale events while preventing infection", and FC Tokyo will cooperate with the measures of Amutus Corporation, which has been commissioned by the government.

We are recruiting monitors for the monitoring of the mechanism for preventing the spread of the novel coronavirus during the trial introduction of this new technology. Please read the details of the trial introduction and the conditions and benefits of being a monitor in the link below, and if you agree, please apply.

Details on the conditions and benefits of the □ trial introduction and monitoring can be found here
[URL]https://www.allm.net/2020/11/20/9407/

□ Monitor Recruitment Form is here
【URL】https://bit.ly/35Hr93J
※Application deadline: Nov 25 (Wed)
※We are recruiting up to 200 monitors. In case of a large number of applicants, we will conduct a lottery.
Only those who participate in the monitor will be contacted by email around 11/26 (Thu). (Please note that if you are not selected, you will not receive an email)

□Match Details
Dec 12, 2020 (Sat) Meiji Yasuda J1 League Sec. 31
FC Tokyo vs Sanfrecce Hiroshima (Kickoff at 14:00 / Ajinomoto Stadium)

Other Notes
・Regarding the use of MySOS and various inspections, please follow the explanations and instructions provided by Alm Corporation.
・Tickets that have been issued cannot be resold or transferred.
・If a match is cancelled or postponed for any reason, ticket reissuance will not be provided.
・The minimum necessary personal information for participating in the monitor will be shared between FC Tokyo and Alum Co., Ltd., but it will not be used for any purpose other than the purpose of this trial introduction.
・In this process, there may be cases where you are required to follow the guidelines instructed by the Ministry of Health, Labour and Welfare or the Public Health Center for safety, such as when there is a suspicion of infection with the novel coronavirus or when a positive reaction is detected in the PCR test. Please be aware of this in advance.